US · IRMD
IRadimed Corporation
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Winter Springs, FL 32708
- Website
- iradimed.com
Price · as of 2024-12-31
$87.15
Market cap 1.32B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $55.50 | -36.32% |
| Intrinsic Value(DCF) | $66.58 | -23.6% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | $29.48 | -66.18% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | $1.45 | $9.98 | |||
| 2014 | $14.05 | $84.67 | $154.92 | $3.56 | $10.43 |
| 2015 | $16.79 | $99.92 | $8,005.25 | $6.32 | $72.20 |
| 2016 | $7.80 | $63.31 | $108.73 | $6.28 | $7.21 |
| 2017 | $12.13 | $134.43 | $2.36 | $3.33 | $0.00 |
| 2018 | $22.24 | $54.01 | $3.02 | $6.07 | $20.07 |
| 2019 | $20.85 | $62.78 | $21.74 | $9.19 | $28.66 |
| 2020 | $20.97 | $87.65 | $3.77 | $5.63 | $0.00 |
| 2021 | $43.14 | $50.24 | $26.97 | $9.62 | $29.12 |
| 2022 | $36.52 | $45.40 | $59.29 | $0.00 | $35.06 |
| 2023 | $42.93 | $45.30 | $160.38 | $0.00 | $41.10 |
| 2024 | $51.45 | $55.50 | $100.94 | $0.00 | $29.48 |
AI valuation
Our deep-learning model estimates IRadimed Corporation's (IRMD) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $55.50
- Current price
- $87.15
- AI upside
- -36.32%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$66.58
-23.6% upside
Graham-Dodd
—
— upside
Graham Formula
$29.48
-66.18% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| IRMD | IRadimed Corporation | $87.15 | 1.32B | -36% | -24% | — | -66% | 33.89 | 7.51 | 8.90 | 26.33 | 305.02 | 7.79 | 76.94% | 29.99% | 26.26% | 24.31% | 59.56% | 20.20% | 0.00 | — | 8.84 | 7.38 | -2.29 | 1111.00% | 1171.00% | 22283.00% | 2.70% | 3.01 | 60.30% | 2.10% | 71.10% | 2.77% | 27.31 | 34.04 | 8.19 | 37.09 |
| AHCO | AdaptHealth Corp. | $9.15 | 1.24B | +239% | -53% | — | — | -19.73 | 0.86 | 0.40 | 2.75 | — | -1.18 | 17.52% | 5.74% | -2.18% | -4.27% | 7.18% | -1.50% | 0.12 | 1.76 | 1.02 | 0.67 | 0.16 | -18525.00% | -49.00% | -696.00% | 16.84% | 0.84 | 8.45% | 0.00% | 0.00% | 148.90% | 7.43 | 6.31 | 0.43 | 0.97 |
| AXGN | AxoGen, Inc. | $31.73 | 1.59B | +57% | -27% | -97% | — | -89.88 | 10.95 | 6.27 | 7266.33 | -187.94 | 11.56 | 74.31% | -3.49% | -6.97% | -13.49% | -6.24% | -7.38% | 0.15 | -1.02 | 5.11 | 2.62 | -84.93 | 4783.00% | 2021.00% | -2676364.00% | -0.21% | 0.03 | -2.33% | 0.00% | 0.00% | 4.07% | -177.75 | -475.67 | 6.19 | 8.61 |
| CRON | Cronos Group Inc. | $2.67 | 1.02B | +1,212% | -39% | -5% | — | — | 0.93 | 5.24 | -12.20 | — | 0.99 | 32.46% | -1.51% | -4.89% | 0.00% | -0.69% | 0.00% | 0.00 | — | 19.59 | 18.88 | 52.68 | -12227.00% | 6440.00% | -9734.00% | 0.01% | 0.55 | 0.06% | 0.00% | — | 0.98% | -62.50 | 1207.50 | 0.95 | 12.80 |
| CTEV | Claritev Corporation | $13.47 | 222.6M | +1,151% | -57% | — | — | -0.83 | -1.36 | 0.25 | 10.21 | — | -0.05 | 27.61% | 4.67% | -29.45% | 632.60% | 0.76% | -5.66% | -26.64 | 0.11 | 0.86 | 0.59 | 9.71 | -8303.00% | 374.00% | 1685.00% | -5.18% | 0.45 | -0.27% | 0.00% | 0.00% | 0.00% | 107.70 | -395.26 | 5.03 | -0.45 |
| GDRX | GoodRx Holdings, Inc. | $1.87 | 635.85M | +1,396% | -39% | -10% | +8% | 30.91 | 1.25 | 0.97 | 3.10 | 29.70 | 6.35 | 92.77% | 10.98% | 10.37% | 3.73% | 14.18% | 1.79% | 0.10 | 2.05 | 2.61 | 2.02 | -1.10 | 10407.00% | 57.00% | -3234.00% | 9.94% | 0.55 | 12.45% | 0.00% | 0.00% | 65.21% | 6.53 | 7.43 | 0.72 | 0.29 |
| IART | Integra LifeSciences Hold… | $11.38 | 886.41M | +457% | -63% | — | — | -1.55 | 0.77 | 0.49 | -1.58 | -0.02 | -1.13 | 51.69% | -30.17% | -31.58% | -39.90% | -21.27% | -13.52% | 0.21 | -5.72 | 2.54 | 1.19 | 0.04 | 736120.00% | 153.00% | -22439.00% | -3.88% | 0.11 | -1.46% | 0.00% | 0.00% | 219.53% | -1.53 | -24.24 | 0.46 | 0.59 |
| INMD | InMode Ltd. | $13.75 | 871.18M | +312% | -24% | +30% | -77% | 9.40 | 1.29 | 2.38 | 3.06 | — | 1.29 | 78.54% | 23.05% | 25.33% | 13.53% | 56.67% | 12.09% | 0.02 | — | 9.88 | 8.55 | -2.61 | -3644.00% | -616.00% | -3615.00% | 9.56% | 1.21 | 65.78% | 0.00% | 0.00% | 30.54% | 3.98 | 4.03 | 0.92 | 9.96 |
| MDXG | MiMedx Group, Inc. | $4.89 | 724.22M | +613% | +792% | -34% | +83% | 14.85 | 2.81 | 1.72 | 6.71 | 103.93 | 3.23 | 82.56% | 15.26% | 11.60% | 21.61% | 45.59% | 16.02% | 0.01 | 35.83 | 4.32 | 3.76 | -1.99 | 1429.00% | 1999.00% | 1311.00% | 10.12% | 1.15 | 71.03% | 0.00% | 0.00% | 12.22% | 8.71 | 7.63 | 1.33 | 7.43 |
| OPK | OPKO Health, Inc. | $1.20 | 921.24M | +2,047% | -57% | — | +48% | -4.21 | 0.75 | 1.56 | -20.44 | -1.44 | 3.55 | 61.01% | -36.08% | -37.20% | -17.14% | -14.89% | -10.92% | 0.33 | -2.16 | 3.97 | 3.13 | -0.89 | 29113.00% | -1490.00% | -848.00% | -20.10% | -1.22 | -13.88% | 0.00% | 0.00% | 3.09% | -4.53 | -5.20 | 1.64 | -0.35 |
| TNDM | Tandem Diabetes Care, Inc… | $25.30 | 1.72B | +78% | -60% | — | — | -8.29 | 10.94 | 1.67 | -10.59 | -7.76 | 10.94 | 52.31% | -7.70% | -20.17% | -97.88% | -25.81% | -22.15% | 2.86 | -9.88 | 2.55 | 1.89 | -2.03 | 10680.00% | 793.00% | -69409.00% | -1.75% | -0.04 | -9.80% | 0.00% | 0.00% | 2.97% | -23.67 | -62.33 | 1.82 | 0.78 |
About IRadimed Corporation
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
- CEO
- Roger E. Susi
- Employees
- 160
- Beta
- 1.14
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($66.58 ÷ $87.15) − 1 = -23.6% (DCF, example).